Crop Life Science (NSE:CLSL) YoY EBITDA Growth: 23.37% (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

NSE:CLSL Crop Life Science Ltd NSE:CLSL
74 GF Score
Price ₹83.00
GF Value ₹57.43
Valuation Significantly Overvalued
! 10 Warning Signs
View Full Analysis

What is Crop Life Science YoY EBITDA Growth?

Crop Life Science NSE:CLSL 74 YoY EBITDA Growth is 23.37% as of Mar. 2026. GuruFocus rates NSE:CLSL with a GF Score™ of 74/100 and a GF Value™ of ₹57.43 (Significantly Overvalued). The stock has 10 warning signs investors should review.

YoY EBITDA Growth is the percentage change of EBITDA per Share over the past twelve months. Crop Life Science's YoY EBITDA Growth for the quarter that ended in Mar. 2026 was 23.37%.

Crop Life Science's EBITDA per Share for the six months ended in Mar. 2026 was ₹6.18.

Crop Life Science YoY EBITDA Growth Historical Data

* Premium members only.

The historical data trend for Crop Life Science's YoY EBITDA Growth can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Crop Life Science YoY EBITDA Growth Chart

Crop Life Science Annual Data
Trend Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
YoY EBITDA Growth
Get a 7-Day Free Trial -13.38 55.13 24.74 10.21 12.56

Crop Life Science Semi-Annual Data
Mar20 Mar21 Mar22 Sep22 Mar23 Sep23 Mar24 Sep24 Mar25 Sep25 Mar26
YoY EBITDA Growth Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only -10.96 -23.42 32.67 63.99 23.37
NSE:CLSL
74GF Score
Crop Life Science Ltd NSE:CLSL
YoY EBITDA Growth is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Crop Life Science YoY EBITDA Growth Calculation

YoY EBITDA Growth is the percentage change of EBITDA per Share over the past twelve months.

Crop Life Science's YoY EBITDA Growth for the fiscal year that ended in Mar. 2026 is calculated as:

YoY EBITDA Growth (A: Mar. 2026 )
=(EBITDA per Share (A: Mar. 2026 )-EBITDA per Share (A: Mar. 2025 ))/ | EBITDA per Share (A: Mar. 2025 ) |
=(11.169-9.923)/ | 9.923 |
=12.56 %

Crop Life Science's YoY EBITDA Growth for the quarter that ended in Mar. 2026 is calculated as:

YoY EBITDA Growth (Q: Mar. 2026 )
=(EBITDA per Share (Q: Mar. 2026 )-EBITDA per Share (Q: Mar. 2025 )) / | EBITDA per Share (Q: Mar. 2025 )) |
=(6.182-5.011)/ | 5.011 |
=23.37 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about YoY EBITDA Growth →
What does a YoY EBITDA Growth of 23.37% mean?
Crop Life Science (NSE:CLSL) has a YoY EBITDA Growth of 23.37% as of Mar. 2026. YoY EBITDA Growth is the percentage change of EBITDA per share over the past 12-month. View historical data for Crop Life Science and its competitors.
Is Crop Life Science's YoY EBITDA Growth too high?
Crop Life Science's current YoY EBITDA Growth is 23.37%. Overall, Crop Life Science has a GF Score™ of 74/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Crop Life Science's YoY EBITDA Growth compare to CTVA and CF?
Crop Life Science's YoY EBITDA Growth of 23.37% can be compared against companies in the Agriculture industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good YoY EBITDA Growth for an Agriculture company?
A good YoY EBITDA Growth depends on the Agriculture industry context. However, YoY EBITDA Growth should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high YoY EBITDA Growth mean?
A high YoY EBITDA Growth can signal that a stock is expensive relative to its fundamentals. YoY EBITDA Growth is the percentage change of EBITDA per share over the past 12-month. View historical data for Crop Life Science and its competitors. Crop Life Science's current YoY EBITDA Growth is 23.37%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Crop Life Science stock overvalued right now?
Based on GuruFocus' analysis, Crop Life Science (NSE:CLSL) is currently considered Significantly Overvalued. The stock's GF Value™ is ₹57.43, compared to a current price of ₹83.00 — trading 44.5% above its estimated fair value. The current YoY EBITDA Growth is 23.37%. Crop Life Science's overall GF Score™ is 74/100 with 10 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is YoY EBITDA Growth calculated?
YoY EBITDA Growth is calculated from a company's financial statements. For Crop Life Science (NSE:CLSL), the current YoY EBITDA Growth is 23.37% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Crop Life Science (NSE:CLSL) Overvalued in 2026?

Based on GuruFocus' analysis, Crop Life Science stock appears to be overvalued. The current stock price of ₹83.00 is trading 44.5% above its estimated GF Value™ of ₹57.43. GuruFocus considers Crop Life Science to be Significantly Overvalued.

Key valuation signals for NSE:CLSL:

  • YoY EBITDA Growth: 23.37%
  • GF Value™: ₹57.43 vs. price of ₹83.00 (44.5% above fair value)
  • GF Score™: 74/100 with 10 warning signs

No single metric tells the full story. See the NSE:CLSL stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Crop Life Science Business Description

Address Old Padra Road, 6th Floor, ABS Tower, Near Chakli Circle, Vadodara, GJ, IND, 390007
Crop Life Science Ltd manufactures and distributes a broad range of crop protection chemicals, including pesticides, insecticides, fungicides, herbicides, micro fertilizers, bio-pesticides, bio-fertilizers, plant growth regulators, and soil plant health products. The company operates its manufacturing facility in Ankleshwar, Gujarat, leveraging technology to maintain quality standards. It serves agricultural markets within India and exports to countries including Indonesia, Bangladesh, Egypt, Myanmar, Vietnam, and Sudan. Segments include Agro chemicals and Agro trade. Revenue is generated through the sale of its agricultural chemicals and related products to farmers, distributors, and agri-businesses.
74GF Score

Get the complete analysis for NSE:CLSL

YoY EBITDA Growth is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹83.00
Price
₹57.43
GF Value